Literature DB >> 23138985

Chronic kidney disease in adolescent and adult patients with phenylketonuria.

Julia B Hennermann1, Sylvia Roloff, Jutta Gellermann, Ilka Vollmer, Elke Windt, Barbara Vetter, Ursula Plöckinger, Eberhard Mönch, Uwe Querfeld.   

Abstract

OBJECTIVES: A lifelong phenylalanine-restricted diet with supplementation of a phenylalanine-free amino acid formula is recommended in patients with phenylketonuria (PKU). The effect of a long-term PKU diet on renal function and blood pressure has not been investigated yet.
DESIGN: We analyzed renal function in 67 patients with PKU, aged 15-43 years, by measuring glomerular filtration rate (GFR) and effective renal plasma flow by isotope clearance ((51)Cr-EDTA, (123)J-Hippuran), estimated GFR, blood retention parameters, urinary protein and electrolyte excretion. Renal ultrasound and 24 h ambulatory blood pressure monitoring were performed additionally. Patients were divided into three groups according to their: 1) current diet (CD), i.e., daily protein intake: ICD <0.8 g/kg, IICD 0.8-1.04 g/kg, IIICD >1.04 g/kg; 2) life-long diet time (LDT), i.e., cumulative years of life in which daily protein intake exceeded dietary recommendations: ILDT <15 years, IILDT 15-19 years, IIILDT >19 years.
RESULTS: GFR was decreased in 19 % of the patients. With increasing protein intake, GFR decreased significantly (ICD 111 ml/min; IICD 105 ml/min; IIICD 99 ml/min. ILDT 112 ml/min; IILDT 103 ml/min; IIILDT 99 ml/min). Proteinuria was detected in 31 %, microalbuminuria in 7 %, and hypercalciuria in 23 % of the patients. 23 % of the patients had arterial hypertension, and 41 % revealed a nocturnal non-dipping status.
CONCLUSIONS: In patients with PKU on a lifelong diet we could detect impaired renal function in 19 %, proteinuria in 31 %, and arterial hypertension in 23 %. Thus, chronic kidney disease may develop in PKU patients, and routine renal function tests should be performed during long-term follow-up.

Entities:  

Mesh:

Year:  2012        PMID: 23138985     DOI: 10.1007/s10545-012-9548-0

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN: 0141-8955            Impact factor:   4.982


  48 in total

Review 1.  Podocytes as a target for treatment with ACE inhibitors and/or angiotensin-receptor blockers.

Authors:  Wilhelm Kriz
Journal:  Kidney Int       Date:  2004-01       Impact factor: 10.612

2.  New reference values for vitamin D.

Authors: 
Journal:  Ann Nutr Metab       Date:  2012-06-01       Impact factor: 3.374

3.  Management of patients with chronic kidney disease.

Authors:  Francesco P Schena
Journal:  Intern Emerg Med       Date:  2011-10       Impact factor: 3.397

4.  High protein intake associates with cardiovascular events but not with loss of renal function.

Authors:  Nynke Halbesma; Stephan J L Bakker; Desiree F Jansen; Ronald P Stolk; Dick De Zeeuw; Paul E De Jong; Ronald T Gansevoort
Journal:  J Am Soc Nephrol       Date:  2009-05-14       Impact factor: 10.121

Review 5.  Dietary protein and renal function.

Authors:  A J King; A S Levey
Journal:  J Am Soc Nephrol       Date:  1993-05       Impact factor: 10.121

6.  Human phenylalanine hydroxylase gene expression in kidney and other nonhepatic tissues.

Authors:  U Lichter-Konecki; C M Hipke; D S Konecki
Journal:  Mol Genet Metab       Date:  1999-08       Impact factor: 4.797

7.  Urinary metabonomics study on biochemical changes in an experimental model of chronic renal failure by adenine based on UPLC Q-TOF/MS.

Authors:  Ying-Yong Zhao; Jing Liu; Xian-Long Cheng; Xu Bai; Rui-Chao Lin
Journal:  Clin Chim Acta       Date:  2011-12-24       Impact factor: 3.786

8.  Long-term high intake of whole proteins results in renal damage in pigs.

Authors:  Yong Jia; Sun Young Hwang; James D House; Malcolm R Ogborn; Hope A Weiler; Karmin O; Harold M Aukema
Journal:  J Nutr       Date:  2010-07-28       Impact factor: 4.798

9.  Protein insufficiency and linear growth restriction in phenylketonuria.

Authors:  Georgianne L Arnold; Catherine J Vladutiu; Russell S Kirby; Eileen M Blakely; Jane M Deluca
Journal:  J Pediatr       Date:  2002-08       Impact factor: 4.406

10.  Protein and albumin-to-creatinine ratios in random urines accurately predict 24 h protein and albumin loss in patients with kidney disease.

Authors:  Mark Guy; Joanna K Borzomato; Ronald G Newall; Philip A Kalra; Christopher P Price
Journal:  Ann Clin Biochem       Date:  2009-09-03       Impact factor: 2.057

View more
  16 in total

1.  Nutritional status in patients with phenylketonuria using glycomacropeptide as their major protein source.

Authors:  A Pinto; M F Almeida; P C Ramos; S Rocha; A Guimas; R Ribeiro; E Martins; A Bandeira; A MacDonald; J C Rocha
Journal:  Eur J Clin Nutr       Date:  2017-04-12       Impact factor: 4.016

2.  Unknown pathomechanisms of renal impairment in PKU.

Authors:  Julia B Hennermann; Uwe Querfeld
Journal:  J Inherit Metab Dis       Date:  2013-09-17       Impact factor: 4.982

3.  Does the PKU diet contribute to impaired renal function?

Authors:  Denise M Ney
Journal:  J Inherit Metab Dis       Date:  2013-05-08       Impact factor: 4.982

4.  A child with phenylketonuria and focal segmental glomerulosclerosis, the bright side of proteinuria.

Authors:  Fatma Rabah; Khalid Al-Thihli; Mohamed El-Naggari; Ibtisam B Elnour
Journal:  Metab Brain Dis       Date:  2017-04-07       Impact factor: 3.584

5.  Minimal Change Disease and Phenylketonuria in an Adult Patient: The Two Sides of Protein Homeostasis.

Authors:  Cristina Pires Correia; Inês Neves; Paulo Chaves; Teresa Cardoso; Roberto Silva; Jorge Almeida
Journal:  Eur J Case Rep Intern Med       Date:  2020-07-31

6.  Glycomacropeptide is a prebiotic that reduces Desulfovibrio bacteria, increases cecal short-chain fatty acids, and is anti-inflammatory in mice.

Authors:  Emily A Sawin; Travis J De Wolfe; Busra Aktas; Bridget M Stroup; Sangita G Murali; James L Steele; Denise M Ney
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-08-06       Impact factor: 4.052

Review 7.  The complete European guidelines on phenylketonuria: diagnosis and treatment.

Authors:  A M J van Wegberg; A MacDonald; K Ahring; A Bélanger-Quintana; N Blau; A M Bosch; A Burlina; J Campistol; F Feillet; M Giżewska; S C Huijbregts; S Kearney; V Leuzzi; F Maillot; A C Muntau; M van Rijn; F Trefz; J H Walter; F J van Spronsen
Journal:  Orphanet J Rare Dis       Date:  2017-10-12       Impact factor: 4.123

Review 8.  Phenylketonuria: translating research into novel therapies.

Authors:  Gladys Ho; John Christodoulou
Journal:  Transl Pediatr       Date:  2014-04

9.  Metabolite Signature of Albuminuria Involves Amino Acid Pathways in 8661 Finnish Men Without Diabetes.

Authors:  Lilian Fernandes Silva; Jagadish Vangipurapu; Ulf Smith; Markku Laakso
Journal:  J Clin Endocrinol Metab       Date:  2021-01-01       Impact factor: 5.958

10.  Glycomacropeptide for nutritional management of phenylketonuria: a randomized, controlled, crossover trial.

Authors:  Denise M Ney; Bridget M Stroup; Murray K Clayton; Sangita G Murali; Gregory M Rice; Frances Rohr; Harvey L Levy
Journal:  Am J Clin Nutr       Date:  2016-07-13       Impact factor: 7.045

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.